世界の神経修復・神経再生市場：異種移植片、神経調節、手術など...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 20)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data Points From Primary Sources
1.6.4 Key Data Points From Secondary Sources
1.6.5 Assumptions

2 Executive Summary (Page No. – 33)

3 Market Overview (Page No. – 37)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increasing Incidence Of Peripheral Nerve Injuries & Neurological Disorders To Propel Market Growth
3.3.1.2 Technological Advancements In Nerve Repair To Boost The Market
3.3.1.3 Favorable Reimbursement Policies Encourage The Product Usage
3.3.1.4 Expanded Target Applications And New Indications Are Expected To Stimulate The Growth Of Neuromodulation Devices
3.3.2 Restraints
3.3.2.1 Lack Of Surgeons And Patient Awareness To Hamper The Growth
3.3.2.2 Lack Of Trained Professionals To Pose A Negative Impact On The Market Growth
3.3.3 Opportunities
3.3.3.1 Novel Therapies Such As Use Of Stem Cells
3.3.3.2 Emerging Markets
3.3.4 Challenges
3.3.4.1 Donor Site Morbidity
3.3.4.2 Inadequate Nerve Regeneration By Conduits
3.4 Regulations For Nerve Repair And Regeneration Products
3.4.1 Regulations For Humanitarian Use Devices (Hud)
3.4.2 Regulations For Electrically Powered Devices
3.5 Strategic Benchmarking
3.5.1 Agreement Of Alafair Biosciences With University Of Texas
3.5.2 Acquisition Of Synovis Life Technologies, Inc. By Baxter International, Inc.
3.5.3 Acquisition Of Intelect Medical, Inc. By Boston Scientific Corporation 47
3.5.4 Agreement Of Cyberonics, Inc. With Cerbomed, Gmbh
3.5.5 New Product Launch By Polyganics
3.6 Market Share Analysis
3.6.1 Neuromodulation Market
3.6.1.1 Global
3.6.1.2 North America
3.6.1.3 Europe
3.6.1.4 Asia
3.6.2 Peripheral Nerve Repair Market
3.6.2.1 Global
3.6.2.2 North America
3.6.2.3 Europe
3.6.2.4 Asia

4 Global Nerve Repair And Regeneration Market (Page No. – 57)
4.1 Introduction
4.2 Regeneration Market, By Surgery
4.2.1 Direct Neurorrhaphy
4.2.1.1 Epineural Repair
4.2.1.2 Perineural Repair
4.2.1.3 Group Fascicular Repair
4.2.2 Nerve Grafting
4.2.2.1 Autografts
4.2.2.2 Allografts
4.2.2.3 Xenografts
4.2.3 Stem Cell Therapy
4.2.4 Neurostimulation/Neuromodulation Surgery
4.2.4.1 External Neurostimulation/Neuromodulation Surgery
4.2.4.2 Internal Neurostimulation/Neuromodulation Surgery
4.3 Regeneration Market, By Products
4.3.1 Nerve Repair By Biomaterials
4.3.1.1 Nerve Conduits
4.3.1.2 Nerve Protectors
4.3.1.3 Nerve Wraps
4.3.1.4 Nerve Connectors
4.3.2 Nerve Repair By Neurostimulation/ Neuromodulation
4.3.2.1 Internal Neurostimulation
4.3.2.1.1 Spinal Cord Stimulation
4.3.2.1.2 Deep Brain Stimulation
4.3.2.1.3 Sacral Nerve Stimulation
4.3.2.1.4 Vagus Nerve Stimulation
4.3.2.1.5 Gastric Electrical Stimulation
4.3.2.2 External Neurostimulation
4.3.2.2.1 Transcutaneous Electrical Nerve Stimulation
4.3.2.2.2 Transcranial Magnetic Stimulation

5 Geographic Analysis (Page No. – 115)
5.1 Introduction
5.2 North America
5.3 Europe
5.4 Asia
5.5 Rest Of The World

6 Competitive Landscape (Page No. – 148)
6.1 Introduction
6.2 Mergers & Acquisitions
6.3 Agreements, Partnerships, Collaborations & Joint Ventures
6.4 New Product Launch
6.5 Expansions
6.6 Approvals

7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 158)
7.1 Alafair Biosciences, Inc.
7.2 Axogen, Inc.
7.3 Baxter International, Inc.
7.4 Biocontrol Medical
7.5 Boston Scientific Corporation
7.6 Cyberonics, Inc.
7.7 Integra Lifesciences Holdings Corp.
7.8 Medtronic, Inc.
7.9 Orthomed S.A.S.
7.10 Polyganics
7.11 Salumedica
7.12 St. Jude Medical
7.13 Stryker Corporation
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

Appendix (Page No. – 225)